Skip to main content
. 2022 Aug 25;2022:9148257. doi: 10.1155/2022/9148257

Figure 1.

Figure 1

α-KG not only remarkably increased after SAH but also predicted the prognosis of SAH patients. (a) α-KG levels in cerebrospinal fluid in the control group and 1-3 days after subarachnoid hemorrhage (C1) and 5-7 days after subarachnoid hemorrhage (C2) (Kruskal-Wallis); 21 patients who have both C1 and C2 were compared by paired tests (paired t-test). (b) Glucose levels of 1-3 days after hemorrhage (B1), 5-7 days after hemorrhage (B2), and the day before discharge (Kruskal-Wallis); 21 patients who have both B1 and B2 were compared by paired tests (paired t-test). (c, d) The levels of α-KG in cerebrospinal fluid 1-3 days and 5-7 days after hemorrhage in the two groups with different outcomes (unpaired t-test, F = 1.51; F = 2.28). (e, f) Blood glucose levels 1-3 days and 5-7 days after bleeding in patients with different outcomes (unpaired t-test, F = 1.78; F = 1.81). (g) The correlation analysis and stratified analysis between α-KG levels in C1 and HUNT-HESS score (Spearman analysis). (h) Receiver operating characteristic curves for α-KG levels in C1 and glucose levels in B1 (∗P < 0.05; ∗∗P < 0.01; ns: no significance).